Qiagen NV | QIA - Operating Expenses


Qiagen NV reported $393.64M in Operating Expenses for its fiscal quarter ending in June of 2026.





Operating Expenses Change Date
Akebia Therapeutics USD 63.08M 8.26M Dec/2025
Alaunos Therapeutics USD 1.01M 175K Mar/2026
argenx SE USD 1.02B 118M Jun/2026
Avita Medical AUD 28.02M 1.55M Dec/2025
Dianthus Therapeutics USD 47M 22.83M Mar/2026
Ionis Pharmaceuticals USD 370.24M 6.24M Jun/2026
IQVIA Holdings USD 1.77B 4.45B Jun/2026
Moderna USD 960M 817M Jun/2026
Organon & Co USD 1.01B 103M Jun/2026
Qiagen NV USD 393.64M 17.95M Jun/2026
Revvity USD 603.55M 24.8M Jun/2026
Tectonic Therapeutic USD 27.3M 5.78M Mar/2026
Viatris USD 3.68B 145.9M Jun/2026
Xeris Pharmaceuticals USD 75.21M 6.18M Mar/2026